Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Antifibrinolytic Drugs Market Report by Indication (Gynecology, Hereditary Angioedema, Fibrinolytic Response Testing, Surgeries, and Others), Form (Oral, Injectable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Trauma Centers, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5672
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Antifibrinolytic Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Gynecology
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hereditary Angioedema
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Fibrinolytic Response Testing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Surgeries
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Form
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectable
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Trauma Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ACIC Pharmaceuticals Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Akorn Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Aurobindo Pharma Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Ferring Pharmaceuticals
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Novartis AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Pfizer Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Takeda Pharmaceutical Company Limited
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Viatris Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Vitruvias Therapeutics Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
List of Figures
Figure 1: Global: Antifibrinolytic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifibrinolytic Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antifibrinolytic Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antifibrinolytic Drugs Market: Breakup by Indication (in %), 2023
Figure 5: Global: Antifibrinolytic Drugs Market: Breakup by Form (in %), 2023
Figure 6: Global: Antifibrinolytic Drugs Market: Breakup by End User (in %), 2023
Figure 7: Global: Antifibrinolytic Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Antifibrinolytic Drugs (Gynecology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Antifibrinolytic Drugs (Gynecology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Antifibrinolytic Drugs (Surgeries) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Antifibrinolytic Drugs (Surgeries) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Antifibrinolytic Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Antifibrinolytic Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Antifibrinolytic Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Antifibrinolytic Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Antifibrinolytic Drugs (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Antifibrinolytic Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Antifibrinolytic Drugs (Trauma Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Antifibrinolytic Drugs (Trauma Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Antifibrinolytic Drugs (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Antifibrinolytic Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Antifibrinolytic Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Antifibrinolytic Drugs Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Antifibrinolytic Drugs Industry: SWOT Analysis
Figure 80: Global: Antifibrinolytic Drugs Industry: Value Chain Analysis
Figure 81: Global: Antifibrinolytic Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Antifibrinolytic Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 3: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Form (in Million US$), 2024-2032
Table 4: Global: Antifibrinolytic Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Antifibrinolytic Drugs Market: Competitive Structure
Table 7: Global: Antifibrinolytic Drugs Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More